Miski Aghnia Khairinisa

Dr. Miski Aghnia Khairinisa

Program Study of Pharmacy, Faculty of Mathematics and Natural Sciences, Universitas Islam Bandung
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
AMAisyah Tri Mulyani
Aisyah Tri Mulyani
MKMiski Aghnia Khairinisa
Miski Aghnia Khairinisa
AKAlfi Khatib
Alfi Khatib
ACAnis Yohana Chaerunisaa
Anis Yohana Chaerunisaa
Stunting is a major global health concern, particularly in low- and middle-income countries, due to its persistently high prevalence. It often originates from chronic malnutrition during the critical first 1000 days of life. Maternal and child nutrition are critical determinants of a child’s growth and development. This article aimed to explore the impact, causes, and evidence-based strategies to accelerate the reduction of stunting incidence worldwide. This review was undertaken with sources from PubMed, Scopus, Google Scholar, Science Direct, and MEDLINE from October 2024 to January 2025. This review was undertaken with sources from PubMed, Scopus, Google Scholar, Science Direct, and MEDLINE from October 2024 to January 2025 using the keyword “Stunting”, “Causes of stunting”, “Stunting Impact”, “Stunting Intervention”, and “Stunting Prevention”. The findings highlight the multifactorial causes of stunting, including maternal malnutrition, inadequate breastfeeding and complementary feeding, poor sanitation, and socioeconomic factors. Stunting is associated with impaired linear growth, cognitive deficits, gut dysbiosis, endocrine disruption, anemia, and increased risk of chronic diseases later in life. Addressing stunting demands multisectoral strategies focusing on maternal and child nutrition, infection prevention, improved WASH (Water, Sanitation, and Hygiene) practices, and socioeconomic support. The evidence presented may guide policy development and targeted interventions to prevent stunting and its long-term effects.

9 February 2025 in Artificial Cells, Nanomedicine, and Biotechnology
Verified
Journal Article
Open access
SSShela Salsabila
Shela Salsabila
MKMiski Aghnia Khairinisa
Miski Aghnia Khairinisa
Nasrul WathoniNasrul Wathoni
Nasrul Wathoni
Irna SufiawatiIrna Sufiawati
Irna Sufiawati
WAN EZUMI MOHD FUADWAN EZUMI MOHD FUAD
WAN EZUMI MOHD FUAD
Muchtaridi MuchtaridiMuchtaridi Muchtaridi
Muchtaridi Muchtaridi
Chitosan nanoparticles have been extensively utilised as polymeric drug carriers in nanoparticles formulations due to their potential to enhance drug delivery, efficacy, and safety. Numerous toxicity studies have been previously conducted to assess the safety profile of chitosan-based nanoparticles. These toxicity studies employed various methodologies, including test animals, interventions, and different routes of administration. This review aims to summarise research on the safety profile of chitosan-based nanoparticles in drug delivery, with a focus on general toxicity tests to determine LD50 and NOAEL values. It can serve as a repository and reference for chitosan-based nanoparticles, facilitating future research and further development of drugs delivery system using chitosan nanoparticles. Publications from 2014 to 2024 were obtained from PubMed, Scopus, Google Scholar, and ScienceDirect, in accordance with the inclusion and exclusion criteria.The ARRIVE 2.0 guidelines were employed to evaluate the quality and risk-of-bias in the in vivo toxicity studies. The results demonstrated favourable toxicity profiles, often exhibiting reduced toxicity compared to free drugs or substances. Acute toxicity studies consistently reported high LD50 values, frequently exceeding 5000 mg/kg body weight, while subacute studies typically revealed no significant adverse effects. Various routes of administration varied, including oral, intravenous, intraperitoneal, inhalation, and topical, each demonstrating promising safety profiles.

21 July 2022 in Drug, Healthcare and Patient Safety
Verified
Journal Article
Open access
PDF file
PAPungki Afifah Asyraf
Pungki Afifah Asyraf
IKIvanna Fauziyah Kusnadi
Ivanna Fauziyah Kusnadi
JSJonathan Stefanus
Jonathan Stefanus
MKMiski Aghnia Khairinisa
Miski Aghnia Khairinisa
RARizky Abdulah
Rizky Abdulah
Drug hypersensitivity is an inflammatory or immune reaction induced by drugs. It can be fatal if not appropriately treated and cause the risk of long-term complications. Sulfonamides are classified as antimicrobial drugs with a broad spectrum effective for gram-positive and gram-negative bacteria. This antibacterial agent works by competitively inhibiting folic acid synthesis, which prevents the growth and proliferation of microorganisms. In its use as antibiotics, sulfonamides can also cause adverse reactions in specific individuals. It has been widely reported that sulfonamide antimicrobials cause hypersensitivity reactions mediated by IgE or T cells. This review identifies symptoms or signs that can appear, as well as genes associated with sulfonamide hypersensitivity reactions, as sulfonamide may cause hypersensitivity in the form of uveitis, skin rash, Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN), parotitis, angioedema, drug reaction with eosinophilia and systemic symptoms (DRESS), and pruritus. In addition, several genes were found to be associated with sulfonamide hypersensitivity, including HLA-A29, HLA-B12, HLA-DR7, HLA-B44, and HLA A*11:01.

7 December 2023 in Brain Sciences
Verified
Journal Article
Open access
PDF file
MKMiski Aghnia Khairinisa
Miski Aghnia Khairinisa
ILIrma Rahayu Latarissa
Irma Rahayu Latarissa
NANadiyah Salma Athaya
Nadiyah Salma Athaya
VCVandie Charlie
Vandie Charlie
HMHanif Azhar Musyaffa
Hanif Azhar Musyaffa
IPIrma Melyani Puspitasari
Irma Melyani Puspitasari
Seaweeds, also known as edible marine algae, are an abundant source of phytosterols, carotenoids, and polysaccharides, among other bioactive substances. Studies conducted in the past few decades have demonstrated that substances derived from seaweed may be able to pass through the blood–brain barrier and act as neuroprotectants. According to preliminary clinical research, seaweed may also help prevent or lessen the symptoms of cerebrovascular illnesses by reducing mental fatigue, preventing endothelial damage to the vascular wall of brain vessels, and regulating internal pressure. They have the ability to control neurotransmitter levels, lessen neuroinflammation, lessen oxidative stress, and prevent the development of amyloid plaques. This review aims to understand the application potential of marine algae and their influence on brain development, highlighting the nutritional value of this “superfood” and providing current knowledge on the molecular mechanisms in the brain associated with their dietary introduction.

5 December 2022 in Molecules
Verified
Journal Article
Open access
PDF file
EPEka Sunarwidhi Prasedya
Eka Sunarwidhi Prasedya
HPHasriaton Padmi
Hasriaton Padmi
BIBq Tri Khairina Ilhami
Bq Tri Khairina Ilhami
NMNi Wayan Riyani Martyasari
Ni Wayan Riyani Martyasari
ASAnggit Listyacahyani Sunarwidhi
Anggit Listyacahyani Sunarwidhi
Andri FrediansyahAndri Frediansyah
Andri Frediansyah
The brown macroalgae Sargassum has been reported for its anti-UV and photoprotective potential for industrial applications. This study evaluated the melanin inhibition activity of Sargassum cristaefolium (SCE) ethanol extract. Melanogenesis inhibition by SCE was assessed in vitro with B16-F10 melanoma cell models and in silico against melanin regulatory proteins Tyrosinase (TYR) and Melanocortin 1 Receptor (MC1R). The regulatory properties evaluated were the melanin content, intracellular tyrosinase activity and cellular antioxidant activities. In addition, the bioactive compounds detected in SCE were subjected to molecular docking against TYR and MC1R. Based on the results, 150 µg/mL SCE effectively inhibited the production of melanin content and intracellular tyrosinase activity. Cellular tyrosinase activity was reduced by SCE-treated cells in a concentration-dependent manner. The results were comparable to the standard tyrosinase inhibitor kojic acid. In addition, SCE effectively decreased the intracellular reactive oxygen species (ROS) levels in B16-F10 cells. The antioxidant properties may also contribute to the inhibition of melanogenesis. In addition, LCMS UHPLC-HR-ESI-MS profiling detected 33 major compounds. The results based on in silico study revealed that the bioactive compound putative kaurenoic acid showed a strong binding affinity against TYR (−6.5 kcal/mol) and MC1R (−8.6 kcal/mol). However, further molecular analyses are needed to confirm the mechanism of SCE on melanin inhibition. Nevertheless, SCE is proposed as an anti-melanogenic and antioxidant agent, which could be further developed into cosmetic skin care products.

MKMiski Aghnia Khairinisa
Miski Aghnia Khairinisa
WAWinda Ariyani
Winda Ariyani
YTYoshito Tsushima
Yoshito Tsushima
Noriyuki KoibuchiNoriyuki Koibuchi
Noriyuki Koibuchi
Gadolinium (Gd)-based contrast agents (GBCAs) are chemicals injected intravenously during magnetic resonance imaging (MRI) to enhance the diagnostic yield. The repeated use of GBCAs can cause their deposition in the brain, including the cerebellum. Such deposition may affect various cell subsets in the brain and consequently cause behavioral alterations due to neurotoxicity. Caution should thus be exercised in using these agents, particularly in patients who are more likely to have repeated enhanced MRIs during their lifespan. Further studies are required to clarify the toxicity of GBCAs, and potential mechanisms causing neurotoxicity have recently been reported. This review introduces the effects of GBCAs in the cerebellum obtained from in vitro and in vivo studies and considers the possible mechanisms of neurotoxicity involved.